| Mon, 25 Sep 2017 15:19:10: | Merck's Keytruda resumes regulatory hot streak with stomach cancer approval
|
| Mon, 25 Sep 2017 15:17:31: | Aegerion to pay $35M to settle claims it risked safety with Juxtapid promotions
|
| Mon, 25 Sep 2017 14:11:27: | Gilead nabs Chinese nod for Sovaldi, eyeing world's largest hepatitis C patient base
|
| Mon, 25 Sep 2017 13:42:34: | What pledge? AbbVie executives may back off their vow to limit price hikes: report
|
| Mon, 25 Sep 2017 12:56:43: | Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer
|
| Fri, 22 Sep 2017 14:54:24: | How to cover Novartis’ $475K CAR-T drug Kymriah? A ‘new payment model’ is the only way, Express Scripts says
|
| Fri, 22 Sep 2017 13:52:01: | FDA flags 19 deaths in Ocaliva patients, putting Intercept's NASH bid in doubt
|
| Fri, 22 Sep 2017 12:59:03: | FiercePharmaAsia—Big Pharma’s performance, Fosun’s revised Gland buy, Arcus-Taiho cancer deal
|
| Thu, 21 Sep 2017 23:29:13: | UDG Healthcare bulks up again with another healthcare agency buy
|
| Thu, 21 Sep 2017 15:31:56: | Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
|
| Thu, 21 Sep 2017 15:15:50: | Johnson & Johnson challenges $417M talc verdict, its largest defeat yet
|
| Thu, 21 Sep 2017 13:41:10: | Will Amazon really get into drug sales? It's in talks with PBMs already, report says
|
| Thu, 21 Sep 2017 13:38:46: | Pfizer hits a snag in bid to jump-start Sutent's flagging kidney cancer sales
|
| Wed, 20 Sep 2017 19:51:49: | Pharma executives wary of value-based deals, but see the potential benefits: PwC
|
| Wed, 20 Sep 2017 14:57:17: | With its Remicade biosimilar stymied by the brand, Pfizer sues Johnson & Johnson for 'anticompetitive' dealmaking
|
| Wed, 20 Sep 2017 13:33:30: | State AGs band together for stepped-up probe into opioid drug marketing
|
| Tue, 19 Sep 2017 19:28:30: | Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
|
| Tue, 19 Sep 2017 14:57:50: | Injunction denied: Pharma argument fails to freeze Nevada drug pricing law
|
| Tue, 19 Sep 2017 13:58:30: | Armed with new data, AbbVie, Roche likely to file early for bigger Venclexta use in CLL: analyst
|
| Tue, 19 Sep 2017 13:40:06: | GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
|
| Mon, 18 Sep 2017 19:44:13: | Johnson & Johnson, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D
|
| Mon, 18 Sep 2017 16:30:36: | Finn's new 'social impact' PR practice aims to help pharma do well by doing good
|
| Mon, 18 Sep 2017 14:43:28: | FDA slaps enrollment hold on 2 Tecentriq studies after Keytruda myeloma trial deaths
|
| Mon, 18 Sep 2017 14:17:39: | Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
|
| Mon, 18 Sep 2017 14:14:28: | Fosun, said to be stymied by India's buyout rules, now aims for smaller Gland Pharma stake in $1.1B deal
|
